Published in Ann Surg Oncol on June 29, 2010
Treatment options for metaplastic breast cancer. ISRN Oncol (2012) 1.30
Primary chondrosarcoma of the breast: a case presentation and review of the literature. World J Surg Oncol (2013) 1.04
Metaplastic breast carcinomas - analysis of prognostic factors in a case series. Contemp Oncol (Pozn) (2014) 1.04
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Br J Cancer (2014) 0.91
Management options in triple-negative breast cancer. Breast Cancer (Auckl) (2011) 0.90
Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center. PLoS One (2015) 0.82
Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study. Cancer Med (2012) 0.79
Metaplastic breast cancer: a comparison between the most common histologies with poor immunohistochemistry factors. BMC Cancer (2015) 0.78
Breast Carcinosarcomas. J Breast Health (2013) (2014) 0.75
Skin-nipple-sparing mastectomy: The first approach in primary myxoid chondrosarcoma of the breast. Int J Surg Case Rep (2017) 0.75
Metaplastic Carcinoma of Breast with Extensive Chondroid Differentiation: A Case Report with Review of Literature. J Clin Diagn Res (2015) 0.75
Axillary metaplastic breast carcinoma with ipsilateral pectoral invasive ductal carcinoma: an unusual presentation. Case Rep Oncol Med (2014) 0.75
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment. Medicine (Baltimore) (2015) 0.75
Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report. Eur J Med Res (2014) 0.75
Metaplastic Breast Carcinoma: Analysis of Clinical and Pathologic Characteristics - A Case Series. J Breast Health (2013) (2016) 0.75
Metaplastic Carcinoma Breast: A Clinical Analysis of Nine Cases. J Clin Diagn Res (2017) 0.75
Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast. Oncol Lett (2017) 0.75
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med (2002) 18.61
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res (2005) 9.70
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med (1997) 7.61
Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol (2006) 2.23
Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol (1989) 2.22
Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol (1999) 2.12
Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol (2006) 2.06
NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) (2009) 2.01
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat (2006) 1.99
Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol (2006) 1.91
Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer (1989) 1.89
Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol (1989) 1.86
Metaplastic breast carcinomas are basal-like tumours. Histopathology (2006) 1.80
Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol (1987) 1.66
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg (1995) 1.66
Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol (1990) 1.62
Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer (1990) 1.57
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat (2008) 1.51
Metaplastic breast cancer: clinical features and outcomes. Am Surg (2005) 1.44
Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol (2008) 1.39
Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat (2005) 1.33
Classification of metaplastic carcinomas of the breast. Pathol Annu (1992) 1.28
Metaplastic carcinoma of the breast: a retrospective review. Int J Radiat Oncol Biol Phys (2005) 1.24
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol (1988) 1.02
Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas. Med Mol Morphol (2008) 0.86
Metaplastic carcinomas and sarcomas of the breast. Am J Clin Pathol (1991) 0.81
The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence. Am J Surg (2008) 1.71
Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med (2009) 1.68
Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol (2008) 1.66
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg (2013) 1.47
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol (2005) 1.40
Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy. Neuro Oncol (2002) 1.36
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res (2006) 1.32
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg (2006) 1.31
Treatment options for metaplastic breast cancer. ISRN Oncol (2012) 1.30
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res (2007) 1.19
Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res (2006) 1.18
Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg (2011) 1.17
The role of surgery in treatment of stage IV melanoma. J Surg Oncol (2006) 1.17
Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem (2009) 1.14
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol (2012) 1.11
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res (2009) 1.11
The clinical significance of MAGEA3 expression in pancreatic cancer. Int J Cancer (2006) 1.11
Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res (2010) 1.10
Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg (2009) 1.10
Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol (2010) 1.08
An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg (2010) 1.05
Sentinel lymph node mapping with GI cancer. Cancer Metastasis Rev (2006) 1.05
Metastatic melanoma - a review of current and future treatment options. Acta Derm Venereol (2015) 1.05
Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol (2010) 1.03
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma Res (2011) 1.03
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg (2011) 0.99
P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy. Hum Pathol (2012) 0.91
Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma. J Surg Res (2010) 0.90
Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis. Cancer Res (2006) 0.89
Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res (2011) 0.88
Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol (2010) 0.86
Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg (2010) 0.86
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res (2012) 0.86
Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol (2011) 0.85
Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res (2011) 0.85
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol (2010) 0.85
Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. J Surg Oncol (2013) 0.84
Negligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections. J Gastrointest Surg (2013) 0.82
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes? Cancer J (2006) 0.78
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring? Rare Tumors (2013) 0.77
Extremity soft tissue tumor surgery by surgical specialty: a comparison of case volume among oncology and non-oncology-designated surgeons. J Surg Oncol (2013) 0.77
Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis. J Surg Res (2013) 0.76
Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol (2012) 0.75
Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res (2012) 0.75
Novel effective drugs and evolving ablation technology: a more comprehensive approach to hepatic malignancies. Ann Surg Oncol (2004) 0.75
Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient care. J Surg Educ (2012) 0.75
Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma. J Surg Res (2013) 0.75